- $1.28bn
- $1.55bn
- $352.21m
- 58
- 33
- 86
- 61
Annual income statement for Imax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 137 | 255 | 301 | 375 | 352 |
| Cost of Revenue | |||||
| Gross Profit | 21.5 | 134 | 156 | 214 | 190 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 259 | 244 | 306 | 324 | 308 |
| Operating Profit | -122 | 11 | -4.83 | 50.4 | 43.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -129 | 11 | -9.77 | 46.1 | 37.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -156 | -9.58 | -19.9 | 33.1 | 32.7 |
| Minority Interest | |||||
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -144 | -22.3 | -22.8 | 25.3 | 26.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -144 | -22.3 | -22.8 | 25.3 | 26.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.24 | -0.473 | -0.236 | 0.555 | 0.534 |